Rachel Tanner

Rachel Tanner

University of Oxford

H-index: 28

Europe-United Kingdom

About Rachel Tanner

Rachel Tanner, With an exceptional h-index of 28 and a recent h-index of 24 (since 2020), a distinguished researcher at University of Oxford, specializes in the field of Tuberculosis, Immunology, Vaccines.

His recent articles reflect a diverse array of research interests and contributions to the field:

Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 …

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a …

Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple …

Development and application of the direct mycobacterial growth inhibition assay: a systematic review

Correlates of protection from tuberculosis

Identification of overlapping MHC-bound peptides presented by Mycobacterium tuberculosis and Mycobacterium bovis BCG infected cells using immunopeptidomics

S109 A seropositive SARS-CoV-2 controlled human infection model demonstrating potent protective immunity and identification of immune correlates of protection

Representation of ethnic and racial minority groups in European vaccine trials: a quantitative analysis of clinical trials registries

Rachel Tanner Information

University

Position

___

Citations(all)

14402

Citations(since 2020)

13656

Cited By

3359

hIndex(all)

28

hIndex(since 2020)

24

i10Index(all)

42

i10Index(since 2020)

40

Email

University Profile Page

Google Scholar

Rachel Tanner Skills & Research Interests

Tuberculosis

Immunology

Vaccines

Top articles of Rachel Tanner

Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 …

The Lancet Microbe

2024/5/1

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a …

The Lancet Infectious Diseases

2024/4/12

Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple …

Tuberculosis

2024/2/13

Rachel Tanner
Rachel Tanner

H-Index: 22

Development and application of the direct mycobacterial growth inhibition assay: a systematic review

2024/2/6

Correlates of protection from tuberculosis

Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges: Focus on Leprosy, Leishmaniasis, Melioidosis and Tuberculosis

2023/3/27

Marco Polo Peralta Alvarez
Marco Polo Peralta Alvarez

H-Index: 8

Rachel Tanner
Rachel Tanner

H-Index: 22

Identification of overlapping MHC-bound peptides presented by Mycobacterium tuberculosis and Mycobacterium bovis BCG infected cells using immunopeptidomics

18th International Congress of Immunology

2023/12/1

S109 A seropositive SARS-CoV-2 controlled human infection model demonstrating potent protective immunity and identification of immune correlates of protection

2023/11/1

Representation of ethnic and racial minority groups in European vaccine trials: a quantitative analysis of clinical trials registries

BMJ Public Health

2023/10/1

Samantha Vanderslott
Samantha Vanderslott

H-Index: 7

Rachel Tanner
Rachel Tanner

H-Index: 22

Determinants of COVID-19 immunisation uptake in a country with high mortality and a low vaccination rate

Journal of Infection and Public Health

2023/8/1

Dunja Aksentijevic
Dunja Aksentijevic

H-Index: 13

Rachel Tanner
Rachel Tanner

H-Index: 22

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants

Nature Communications

2022/11/3

Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model

Journal of Neuroinflammation

2022/12

Rachel Tanner
Rachel Tanner

H-Index: 22

Chronovaccination: Harnessing circadian rhythms to optimize immunisation strategies

2022/10/7

Rachel Tanner
Rachel Tanner

H-Index: 22

Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical study

Scientific reports

2022/5/12

Induction of functional specific antibodies, IgG-secreting plasmablasts and memory B cells following BCG vaccination

Frontiers in immunology

2022/1/5

Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)

bioRxiv

2021/2/15

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Nature medicine

2021/2

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Nature medicine

2021/2

Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease

Tuberculosis

2021/12/1

Rachel Tanner
Rachel Tanner

H-Index: 22

Helen Mcshane
Helen Mcshane

H-Index: 41

Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination

The Lancet

2021/11/6

See List of Professors in Rachel Tanner University(University of Oxford)